X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (526) 526
Book Review (30) 30
Publication (22) 22
Book Chapter (2) 2
Magazine Article (2) 2
Book / eBook (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (454) 454
female (320) 320
diphosphonates - administration & dosage (273) 273
index medicus (262) 262
diphosphonates - therapeutic use (244) 244
bisphosphonates (239) 239
osteoporosis (220) 220
zoledronic acid (205) 205
bone density conservation agents - administration & dosage (194) 194
male (184) 184
diphosphonates - adverse effects (180) 180
middle aged (179) 179
aged (164) 164
bone density conservation agents - therapeutic use (157) 157
infusions, intravenous (138) 138
injections, intravenous (133) 133
ibandronate (128) 128
administration, oral (125) 125
bone neoplasms - secondary (122) 122
bone density conservation agents - adverse effects (121) 121
double-blind (121) 121
endocrinology & metabolism (114) 114
osteoporosis - drug therapy (113) 113
bone neoplasms - drug therapy (112) 112
medicine & public health (103) 103
oncology (103) 103
postmenopausal osteoporosis (98) 98
treatment outcome (91) 91
adult (85) 85
alendronate (85) 85
postmenopausal women (84) 84
bone density - drug effects (83) 83
drug therapy (82) 82
osteoporosis, postmenopausal - drug therapy (81) 81
care and treatment (80) 80
orthopedics (79) 79
bone-mineral density (78) 78
fractures (78) 78
imidazoles - administration & dosage (78) 78
bones (77) 77
drug administration schedule (77) 77
bisphosphonate (74) 74
multiple-myeloma (73) 73
risk factors (73) 73
pamidronate (70) 70
breast-cancer (69) 69
diphosphonates (67) 67
intravenous pamidronate (67) 67
aged, 80 and over (65) 65
pharmacology & pharmacy (65) 65
rheumatology (65) 65
breast neoplasms - pathology (64) 64
skeletal complications (63) 63
women (63) 63
efficacy (62) 62
bone metastases (56) 56
health aspects (55) 55
breast cancer (54) 54
cancer (54) 54
bone density (53) 53
diphosphonates - pharmacology (53) 53
intravenous administration (53) 53
imidazoles - therapeutic use (52) 52
imidazoles - adverse effects (51) 51
research (51) 51
phosphonates (50) 50
therapy (50) 50
ibandronic acid (47) 47
prevention (47) 47
bone mineral density (46) 46
osteonecrosis (46) 46
randomized controlled trials as topic (46) 46
endocrinology (44) 44
medicine, general & internal (44) 44
internal medicine (43) 43
safety (43) 43
metastasis (42) 42
randomized-trial (42) 42
time factors (42) 42
breast neoplasms - drug therapy (41) 41
pain (41) 41
animals (40) 40
bone (40) 40
dose-response relationship, drug (40) 40
intravenous ibandronate (40) 40
surgery (40) 40
double-blind method (39) 39
dentistry (38) 38
dentistry, oral surgery & medicine (38) 38
osteonecrosis - chemically induced (38) 38
risk-factors (38) 38
clinical trials (37) 37
vertebral fractures (37) 37
density (36) 36
bone density conservation agents - pharmacology (35) 35
analysis (34) 34
follow-up studies (34) 34
intravenous (34) 34
risedronate (34) 34
dosage and administration (33) 33
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (518) 518
German (6) 6
Japanese (6) 6
Hungarian (1) 1
Italian (1) 1
Korean (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Osteoporosis International, ISSN 0937-941X, 11/2015, Volume 26, Issue 11, pp. 2685 - 2693
Journal Article
Bone, ISSN 8756-3282, 2011, Volume 49, Issue 6, pp. 1317 - 1322
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2003, Volume 14, Issue 9, pp. 1399 - 1405
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 07/2009, Volume 24, Issue 7, pp. 1335 - 1344
Journal Article
Journal Article
Journal Article
Calcified Tissue International, ISSN 0171-967X, 8/2013, Volume 93, Issue 2, pp. 137 - 146
Journal Article
Journal Article
Journal Article
Medicine, ISSN 0025-7974, 02/2019, Volume 98, Issue 6, p. e14340
Rationale:Few comparative studies have evaluated the differences between intravenous alendronate (ALN) and ibandronate (IBN) in patients with osteoporosis.... 
MEDICINE, GENERAL & INTERNAL | BISPHOSPHONATES | POSTMENOPAUSAL OSTEOPOROSIS | SAFETY | CLINICAL-EFFICACY | alendronate | BONE | osteoporosis | ibandronate | FRACTURE RISK | ADHERENCE | Osteoporosis | Usage | Diagnosis | Alendronate | Drug therapy
Journal Article
Journal Article